Safety of rituximab therapy during the first trimester of pregnancy: a case history.

Abstract

The optimal treatment of non-Hodgkin's lymphoma (NHL) during pregnancy is currently undefined. The potential teratogenic effects of conventional chemotherapy preclude its use during the first trimester of pregnancy. We report the case of a pregnant woman with relapsed indolent follicular NHL who was treated with rituximab (unintentionally) during the first… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.